Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type

Administration of Dienogest prior to hysteroscopic polypectomy is empirically performed, but the physiological effects of Dienogest on endometrial polyps are unclear. We aimed to investigate the effects of Dienogest on the proliferation and inflammation of endometrial polyps. We conducted a retrospe...

Full description

Bibliographic Details
Main Authors: Kei Inaba, Osamu Wada-Hiraike, Miyuki Harada, Yasushi Hirota, Kaori Koga, Tomoyuki Fujii, Yutaka Osuga
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Women's Health
Online Access:https://doi.org/10.1177/1745506520952003
_version_ 1828266169551814656
author Kei Inaba
Osamu Wada-Hiraike
Miyuki Harada
Yasushi Hirota
Kaori Koga
Tomoyuki Fujii
Yutaka Osuga
author_facet Kei Inaba
Osamu Wada-Hiraike
Miyuki Harada
Yasushi Hirota
Kaori Koga
Tomoyuki Fujii
Yutaka Osuga
author_sort Kei Inaba
collection DOAJ
description Administration of Dienogest prior to hysteroscopic polypectomy is empirically performed, but the physiological effects of Dienogest on endometrial polyps are unclear. We aimed to investigate the effects of Dienogest on the proliferation and inflammation of endometrial polyps. We conducted a retrospective case study on 40 menstruating women who underwent hysteroscopic polypectomy at our hospital. We collected clinical data, and the polyps were divided by morphological appearance. The specimens obtained were immunostained for Ki67 as a marker of cellar proliferation and CD138 as a marker of plasmacytes, which are a hallmark of chronic endometritis. Dienogest significantly suppressed the proliferation status of EPs because Dienogest treatment prior to the operation significantly reduced the Ki67 index (41.25 ± 16.85 vs 7.18 ± 9.82, p   <  0.01). We found that sessile-type polyps showed a significantly lower Ki67 index than the pedunculated type (12.28 ± 11.12 vs 2.09 ± 2.73, p  = 0.026). The presence of CD138-positive cells was more pronounced in sessile-type polyps than in pedunculated polyps ( p  = 0.018). However, Dienogest treatment showed no apparent effect on inflammation status, as detected by CD138-positive cells. We revealed that Dienogest suppressed cellular proliferation, and morphological classification of endometrial polyps could be used to predict the responsiveness to Dienogest. However, Dienogest might not affect cellular inflammation.
first_indexed 2024-04-13T04:49:26Z
format Article
id doaj.art-1bc4720f798e4489ad2e6717c62a6fc0
institution Directory Open Access Journal
issn 1745-5065
language English
last_indexed 2024-04-13T04:49:26Z
publishDate 2020-08-01
publisher SAGE Publishing
record_format Article
series Women's Health
spelling doaj.art-1bc4720f798e4489ad2e6717c62a6fc02022-12-22T03:01:43ZengSAGE PublishingWomen's Health1745-50652020-08-011610.1177/1745506520952003Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological typeKei InabaOsamu Wada-HiraikeMiyuki HaradaYasushi HirotaKaori KogaTomoyuki FujiiYutaka OsugaAdministration of Dienogest prior to hysteroscopic polypectomy is empirically performed, but the physiological effects of Dienogest on endometrial polyps are unclear. We aimed to investigate the effects of Dienogest on the proliferation and inflammation of endometrial polyps. We conducted a retrospective case study on 40 menstruating women who underwent hysteroscopic polypectomy at our hospital. We collected clinical data, and the polyps were divided by morphological appearance. The specimens obtained were immunostained for Ki67 as a marker of cellar proliferation and CD138 as a marker of plasmacytes, which are a hallmark of chronic endometritis. Dienogest significantly suppressed the proliferation status of EPs because Dienogest treatment prior to the operation significantly reduced the Ki67 index (41.25 ± 16.85 vs 7.18 ± 9.82, p   <  0.01). We found that sessile-type polyps showed a significantly lower Ki67 index than the pedunculated type (12.28 ± 11.12 vs 2.09 ± 2.73, p  = 0.026). The presence of CD138-positive cells was more pronounced in sessile-type polyps than in pedunculated polyps ( p  = 0.018). However, Dienogest treatment showed no apparent effect on inflammation status, as detected by CD138-positive cells. We revealed that Dienogest suppressed cellular proliferation, and morphological classification of endometrial polyps could be used to predict the responsiveness to Dienogest. However, Dienogest might not affect cellular inflammation.https://doi.org/10.1177/1745506520952003
spellingShingle Kei Inaba
Osamu Wada-Hiraike
Miyuki Harada
Yasushi Hirota
Kaori Koga
Tomoyuki Fujii
Yutaka Osuga
Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
Women's Health
title Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
title_full Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
title_fullStr Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
title_full_unstemmed Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
title_short Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
title_sort dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type
url https://doi.org/10.1177/1745506520952003
work_keys_str_mv AT keiinaba dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype
AT osamuwadahiraike dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype
AT miyukiharada dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype
AT yasushihirota dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype
AT kaorikoga dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype
AT tomoyukifujii dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype
AT yutakaosuga dienogestsuppressescellularproliferationstatusofendometrialpolypsandactsdifferentlydependingonthemorphologicaltype